1. Medtech Insight
  2. >>Business

Digital Platform Caresyntax Extends Series C To Total $130M Raised

 
• By Marion Webb

Caresyntax raised $130m in total funding to expand commercialization of its software that seeks to reduce variability and improve outcomes in the operating room.

Surgicaldata

Caresyntax Corp., a developer of a digital platform intended to reduce surgery-related complications, added $30 million to its earlier series C round, bringing the total funding raised to $130m. Among the new investors are funds and accounts managed by BlackRock and health insurer ProAssurance, venture capital firm Harmonix and existing backers such as Releyns Group, Europe’s largest medical malpractice insurer, and IPF Partners, Caresyntax said in a 16 September announcement.

The added investment builds on the first stage, announced in April, that was led by PFM Health Sciences, LP and...

More from Financing

More from Business

Novel Pathway For Combined Drug/IVD Trials Wins Backing Of EU Nations

 
• By Vibha Sharma

Broad participation by EU member states in a new pilot to test a unified procedure for evaluating applications for combined drug and IVD studies shows they recognize its value, says Monique Al, vice-chair of the Clinical Trials Coordination Group.

‘Be Quick, But Don’t Hurry’: Dexcom CEO Talks CGM Market Success

 
• By Marion Webb

Dexcom’s CEO Kevin Sayer discusses this fall’s planned launch of the 15-day G7 CGM, downplays Abbott’s dual-sensor while focusing on development of multi-analyte G8, making OTC Stelo app more “consumerish” for Europeans, and more.

Medtronic’s ‘Strategic Expansion’ Into Remote Monitoring

 
• By Natasha Barrow

“The Corsano wearable strengthens Medtronic’s acute care and monitoring portfolio,” Marc De Martini, vice president at Medtronic, told Medtech Insight.